Sarcoidosis is a chronic granulomatous disorder characterized by a massive influx of Th1 lymphocytes. Both naive and memory T cells express high levels of interleukin 7 receptor-a (IL7Ra), encoded by the IL7R gene. The purpose of this study was to investigate the role of the IL7R gene region in susceptibility to sarcoidosis. Six common single-nucleotide polymorphisms (SNPs) spanning IL7R were genotyped and analyzed in 475 sarcoidosis patients and 465 healthy controls. Replication of one significant associated SNP was carried out in 206 independent sarcoidosis patients, 127 controls and 126 patients with Lö fgren's disease. The rs10213865 SNP was associated with sarcoidosis (P ¼ 0.008), and in silico analysis showed a complete linkage (r 2 ¼ 1, D 0 ¼ 1) with a functional nonsynonymous coding SNP in exon 6 (rs6897932, T244I). Combined analysis of 663 individuals with sarcoidosis and 586 controls (homozygous carriers of risk allele, P ¼ 5 Â 10 À4
Introduction
Sarcoidosis is a chronic, often disabling disease, affecting 20-50 in 100 000 people in most western countries. The inflammatory lesions typical of sarcoidosis show a massive Th1 lymphocyte influx. Disease susceptibility and progression are thought to depend partly on genetic factors. [1] [2] [3] [4] Of these genetic factors, only the human leukocyte antigen gene complex has been repeatedly confirmed to be associated with sarcoidosis in multiple populations of multiple ethnicity. Polymorphisms in a number of non-human leukocyte antigen genes have been reported to be associated with sarcoidosis, but so far confirmation has been difficult (recently reviewed by Grunewald 5 ). Interleukin 7 receptor-a (IL7Ra) (also known as CD127), encoded by the gene IL7R, is a member of the type I cytokine receptor family and forms a receptor complex with the common cytokine receptor-g chain (g c or CD132) for which IL7 is the ligand, which is produced by stromal cells in lymphoid tissues. Importantly, IL7Ra is a key functional marker of the early heterogeneity observed in effector T cells. [6] [7] [8] Both naive and memory T cells express high levels of IL7Ra, and IL7 is required for their homeostasis. 9 Activation of T cells results in the downregulation of IL7Ra within 48 h after antigenic stimulation, but there is re-expression on the resting memory pool during the course of an immune response. Kaech et al. 7 demonstrated that expression of IL7Ra on a small number of CD8 þ effector cells identifies the subset that is destined to differentiate into true memory cells. Other reports have demonstrated an important function for IL7 in the generation of CD4 þ memory cells as well. 10 Basal levels of IL7 are sufficient to maintain survival of the CD8 þ memory pool and may contribute to the survival of the CD4 þ memory pool. 11 Interestingly, IL7R signaling has an immunomodulatory role in dendritic cells, especially in the context of thymic stromal lymphopoietin (TSLP), which also signals through the IL7Ra in a heterodimeric complex by dimerization with the product of the cytokine receptor-like factor 2 gene (CRLF2) to form the TSLP receptor. TSLP is homologous to IL7 and is produced by the cells of epithelial origin in the thymus, lung, gut and skin. 12 Apart from an indirect effect of TSLP-activated dendritic cells on CD4 þ T-cell homeostasis 13 and T-regulatory cell development in the thymus, 14 Rochman et al. 15 recently demonstrated a direct effect of TSLP on activated CD4 þ cells. The gene IL7R is located on chromosome 5p13, a region linked with multiple sclerosis, 16 asthma 17 and type I diabetes. 18 To date, no studies have been published examining genotypic differences in IL7Ra between sarcoidosis patients and controls. We genotyped six common single-nucleotide polymorphisms (SNPs) spanning IL7R, including the 5 0 promoter, a SNP in intron 5, a nonsynonymous SNP in exon 8 and three haplotypetagging SNPs. Moreover, correlations with disease activity parameters, lung function parameters and bronchoalveolar lavage cell counts were analyzed.
Results
Distribution of IL7R gene variation in sarcoidosis patients and healthy controls IL7R variation and risk of sarcoidosis M Heron et al belonging to the group of amino acids with uncharged polar side chains ( Table 2) .
Replication of the rs10213865 effect
To replicate the SNP association, we genotyped an independent case-control data set of patients presenting in multiple hospitals in The Netherlands in 2008 (206 cases and 127 controls). The frequency of allele A at rs10213865 was similar to the frequency of allele A in the original cohort and higher in sarcoidosis patients (0.76 vs 0.67, P ¼ 0.01). Combined analysis of 663 independent individuals with sarcoidosis and 586 controls (P ¼ 0.0005, OR ¼ 1.49 (1.19-1.86) for recessive genotype coding) provided strong statistical support for a genuine association of IL7R with the risk of sarcoidosis (Table 3) . Furthermore, to test whether the association with IL7R was specific for sarcoidosis, we genotyped 139 patients with Löfgren's syndrome considered as a clinically and genetically distinct granulomatous lung disease. In patients with Löfgren's syndrome, the frequency of allele A at rs10213865 revealed the same distribution as was found in sarcoidosis patients. However, because of the low number of patients no significance was reached when compared with controls (0.74 vs 0.69, P ¼ 0.09) ( Table 4 ).
IL7Ra expression on peripheral blood mononuclear cells and BALF lymphocytes
To explore the biological relevance of the IL7R rs10213865 genotype variation, we measured expression patterns in parallel samples of peripheral blood (PB) mononuclear cells and bronchoalveolar lavage fluid (BALF) from healthy individuals. Analysis of membrane-bound IL7Ra expression in relation to the genotype of the sarcoidoses risk-modifying SNP rs10213865 revealed no significant difference between IL7R genotypes and IL7Ra median fluorescence intensity on PB or BALF lymphocytes (data not shown). Neither did we observe significant differences between rs10213865 AA vs AC þ CC genotypes comparing the percentages or absolute number of PB and BALF lymphocytes, CD4 þ lymphocytes and CD4 þ / CD8 þ ratios (data not shown). þ ratios and serum IL-2R and serum angiotensinconverting enzyme (ACE, corrected for ACE insertion/ deletion genotypes) values measured at presentation ( Figure 2) .
No correlation was observed with radiographic staging at presentation (data not shown). Analysis of pulmonary disease outcome, defined by radiographic staging after minimal 4-year follow-up, revealed no association with IL7R rs10213865 genotypes ( Table 5) .
These data suggest no contribution of IL7R variation to disease severity or activity in clinical overt disease.
Discussion
In this paper, we described an association between an intron SNP in the IL7R gene and sarcoidosis. The novel finding was replicated in a validation cohort revealing the same differences in allele frequencies between sarcoidosis patients and controls. The intron SNP at position rs10213865 was in complete LD with a functional nonsynonymous coding SNP in exon 6 (rs6897932, T244I), leading to an altered membrane-bound/soluble IL7Ra ratio. 19 Gregory et al. 19 demonstrated that transcripts containing the C allele at position rs6897932 resulted in a twofold increase in the skipping of exon 6 by disrupting an exonic splicing silencer compared with transcripts with the T allele, and simultaneously produced less membrane-bound IL7Ra protein leading to a further increase of the soluble form of IL7Ra. This is likely to affect the dynamics of IL7 or TSLP signaling network in multiple cell types 8, 20 and may have a direct impact on the pathogenesis of sarcoidosis.
The frequency of rs10213865 was equally distributed in patients with Lö fgren's disease, although limited numbers prevented it to reach significance. This might suggest that the sarcoidosis-associated allele confers a Variation in IL7R might confer susceptibility to sarcoidosis in the early stages of the response to the 'sarcoidosis antigen' when compromised IL7 signaling may reduce initial immune activation. Persistence of the antigen may lead to clinical overt disease and the influence of IL7R polymorphism might be diminished. This could explain the lack of correlation between IL7R rs10213865 genotypes and clinical parameters measured at presentation or radiography after minimal 4-year follow-up.
In healthy controls, no correlation was found between the sarcoidosis risk genotype and IL7Ra expression on PB or BALF T lymphocytes, although we cannot exclude the possibility that soluble IL7R adhered to the cell membrane which may have increased fluorescence intensity values. Decreased expression in the BALF compartment would have supported a simplistic interpretation of recently activated lymphocytes that have migrated to the lung and subsequently have downregulated IL7Ra.
The mechanism behind the importance of the IL7-IL7Ra ligand-receptor pair in sarcoidosis needs to be Immune response to bacteria 27 may be compromised because of reduced B-and T-cell differentiation. Alternatively, impaired regulatory T-cell function may lead to chronic immune activation and related tissue damage, and may have a function in the granuloma evolution. 28 
Low expression of IL7Ra by CD4
þ CD25 þ T cells correlates with high expression of the nuclear transcription factor FoxP3, and has recently been identified as an important characteristic of peripheral regulatory T cells. 29 Both IL7 and TSLP signaling are required for normal development of the regulatory T cell lineage. 30 It had previously been reported that FoxP3-positive cells required a g c stimulus in addition to the IL2 receptor. 31 A recent study by Mazzucchelli et al. 32 implicated IL7Ra as providing both a g c stimulus, and when paired with the TSLP receptor, a g c -independent stimulus. FoxP3 þ regulatory T cells in active sarcoidosis have been found increased but functionally impaired and unable to suppress granuloma formation in vitro.
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Competition for scarce IL7 between cell types may result in reduced survival of protective cells in sarcoidoses, such as regulatory T cells. In particular, the role of TSLP in sarcoidosis produced by epithelial cells warrants further research. TSLP activates CD11c þ dendritic cells and results in their Th2 cytokine production, 33 reduction in levels of the TSLP receptor may cause a Th1 skew in sarcoidosis.
Here, we reported compelling evidence that polymorphisms in IL7R contribute to the non-human leukocyte antigen genetic risk in sarcoidosis, demonstrating a role for this protein in the pathophysiology of the disease. As the risk genotype is quite common in the general population (with a frequency of 0.48 in individuals of European descent), it is plausible that additional triggers are required for the development and progression of sarcoidosis, which is consistent with a complex disease model in which multiple genes and environmental factors contribute to the phenotype.
Materials and methods

Participants
Original cohort. A total of 475 unrelated Dutch Caucasian sarcoidosis patients were included in this study (male/female; 212/263). The diagnosis sarcoidosis was established when clinical findings were supported by histological evidence and after exclusion of other known causes of granulomatosis in accordance with the consensus of the ATS/ERS/WASOG statement on sarcoidosis. 34 The control individuals comprised 465 healthy, Dutch Caucasian employees of the St Antonius Hospital and blood samples from Sanquin blood bank in the Netherlands. Thirty-nine individuals included in the control group underwent bronchoalveolar lavage. Verbal and written consent was obtained from all participants, and authorization was given by the Ethics Committee of the St Antonius Hospital, Nieuwegein.
Validation cohort. To replicate the results, we included an independent case-control data set of sarcoidosis patients presented to multiple hospitals (within a 30 km radius of St Antonius Hospital) in the Netherlands in 2008 (206 cases and 127 controls).
To test whether the genetic association was specific for sarcoidosis, 139 patients with the classic symptoms of Löfgren's syndrome, namely fever, erythema nodosum, arthralgia and bilateral hilar lymphadenopathy, were included. For these patients the diagnosis was carried out without biopsy proof.
Radiographic staging. Chest radiographs were assessed in consensus by chest physicians specialized in diffuse lung diseases to determine disease severity using standard radiographic staging for sarcoidosis, classified according to the Scadding criteria. 35 Radiographic data at presentation were available for 191 sarcoidosis patients. Radiographic data at pulmonary disease outcome, defined by chest X-ray after a minimum of 4-year follow-up, were available for 309 patients. Patients presenting with pulmonary fibrosis or showing pulmonary fibrosis on chest radiography at follow-up o4-years, were classified as stage IV at disease outcome considering the irreversibility of fibrotic scarring.
Pulmonary function tests. Pulmonary function tests were performed at presentation. Vital capacity (inspiratory) (iVC), forced expiratory volume in 1 s (FEV 1 ) and carbon monoxide diffusing lung capacity (Dlco) were used to assess the presence of lung function impairment at presentation of the disease. All lung function parameters are expressed as percent predicted values. IVC and FEV 1 were calculated from volumes in liters and adjusted to body temperature, ambient pressure, saturated with water vapor. Bronchoalveolar lavage. Bronchoalveolar lavage was performed during flexible fiberoptic bronchoscopy at the time of the diagnosis according to standardized and validated procedure described earlier. 36 BALF was filtered through nylon gauze and centrifuged (10 min at 400 g at 4 1C). The cell pellet was washed twice, counted, and resuspended in minimal essential medium/RPMI 1640 (Gibco; Grand Island, NY, USA), supplemented with 0.5% bovine serum albumin (Organon; Teknika; Boxtel, The Netherlands). Cells were counted in a Bü rker chamber (Omnilabo, Breda, The Netherlands). Cell viability was determined by Trypan blue exclusion. Smears for cell differentiation were prepared by cytocentrifugation (Shandon; Runcorn, UK). Cell differentiation was performed on cytospinslide after staining with May-Grü nwald-Giemsa (Merck; Darmstadt, Germany), at least 2 Â 500 cells were counted.
Assay for IL-2R in serum. Serum IL-2R was quantitatively determined using enzyme-linked immunosorbent assay (AMDS Benelux, Malden, The Netherlands). We used the normal range limited by an upper reference level given by the manufacturer, 710 U ml
À1
.
Assay for ACE in serum. Quantification of ACE activity was measured in lithium heparin plasma using the Bü hlmann ACE kinetic test, according to previously described methods (Bü hlmann Laboratories AG, Schö -nenbuch, Switzerland). 37 Serum ACE concentrations are influenced by an insertion/deletion polymorphism of the ACE gene. The D allele of this polymorphism is linked with raised serum ACE levels. In our analysis, we used the Z-score based on ACE insertion/deletioncorrected reference intervals (II: 9-43, ID: 14-62, DD: 24-82). 37 Analysis of IL7R genetic SNPs. DNA was extracted from whole blood samples and SNPs were analyzed on a custom Illumina goldengate bead SNP assay that was performed in accordance with the manufacturer's recommendations (Illumina, San Diego, CA, USA). Six SNPs in the IL7R gene were selected (Table 1) . Three haplotype-tagging SNPs were selected using the tagger program entering the genomic region of IL7R on genome build 35, using the CEU HapMap analysis panel and preferential picking of SNPs with a minimum allele frequency of 25% and high Illumina design scores under the pair wise tagging options with an r 2 threshold for SNPs 40.8.
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Flow cytometry IL7Ra surface expression ex vivo. Interleukin-7Ra surface expression was measured on T lymphocytes from PB and from BALF of healthy individuals. Fifty ml of PB or BALF, containing at least 100 000 cells, was incubated for 15 min at room temperature with 10 ml of the following monoclonal antibodies: anti-CD3 PE, anti-CD4 PerCP, anti-CD8 APC and anti-CD127 FITC. The lymphocyte population was selected based on forward scatter-side scatter (FSC-SSC) characteristics. Immunofluoresence was measured by flow cytometry (FACS-Calibur, Becton Dickinson, Alphen aan den Rijn, The Netherlands). Fluorescence stability was checked by weekly calibration of the flow cytometer during the time of the experiment. Data were analyzed with FlowJo software (Tree Star, Ashland, OR, USA). During each experiment a total of 50 000 cells were counted.
Statistical analysis
Single SNP analysis. Allele and genotype frequencies were calculated for each locus and tested for HardyWeinberg equilibrium in controls. Case-control association studies were analyzed by w 2 -test using 2 Â 3 and 2 Â 2 contingency tables of genotype and allele frequencies, respectively. Odds ratios and confidence intervals were calculated with an online tool, available at http:// ihg2.helmholtz-muenchen.de/ihg/snps.html.
The significance threshold was set after accounting for multiple comparisons using a Bonferroni correction for the effective number of independent SNPs proposed by Li and Ji. 39 Owing to LD, the effective number of SNPs was 4.001 for IL7R (six genotyped SNPs), resulting in an adjusted significance threshold of 0.05/4.001 ¼ 0.0127 (available at http://gump.qimr.edu.au/general/daleN/ matSpD/).
Haplotype analysis. Haplotype frequencies and tests of haplotype association were determined using Haploview version 4.0. 40 Individual haplotypes were inferred using PHASEv2 software. 41 Analysis of variance was used to test differences between IL7R genotypes and IL7Ra expression. A P-value o0.05 was considered significant.
